Table 3.

Summary of IHC Analyses

candidate biomarker	relative intensity ± STDEV in NSCLC (N = 86)	relative intensity ± STDEV in benign nodule (N = 63)	P value
ALOX5	0.04 ± 0.19	1.90 ± 0.79	<0.001
ALOX5AP	0.00 ± 0.00	0.93 ± 0.71	<0.001
ITGAX	0.00 ± 0.00	2.15 ± 0.81	<0.001
SLC2A3	0.46 ± 0.81	1.59 ± 0.69	<0.001
CEACAM6	1.47 ± 0.95	0.20 ± 0.61	<0.001
CRABP2	1.76 ± 0.89	1.24 ± 0.72	0.004
LAD1	0.58 ± 0.56	0.34 ± 0.43	0.054
CD4 memb	6.8 ± 5.2	18.3 ± 14.3	<0.001
CD8 memb	15.0 ± 11.0	24.4 ± 10.7	<0.001
FOXP3 nuc	21.0 ± 11.0	30.0 ± 16.0	<0.001